ARMISTICE CAPITAL, LLC Supernus Pharmaceuticals, Inc. Transaction History

ARMISTICE CAPITAL, LLC portfolio value:

$155.47M
portfolio value

ARMISTICE CAPITAL, LLC quarter portfolio value change:

+17.05%
quarter

Supernus Pharmaceuticals, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Decrease -2.53% -118.99K shares 19.20M $33.85 4.59M
Q2 2022 share Increase +52.00% 1.61M shares 36.07M $28.92 4.71M
Q1 2022 share Decrease -25.05% -1.03M shares -20.41M $32.32 3.1M
Q4 2021 share Increase +6.05% 236K shares 16.59M $30.03 4.13M
Q3 2021 share Increase +17.33% 576K shares 1.66M $26.67 3.9M
Q2 2021 share Decrease -2.58% -88K shares 13.02M $30.79 3.32M
Q1 2021 share Increase +9.36% 292K shares 10.82M $26.18 3.41M
Q4 2020 share Decrease -2.50% -80K shares 11.81M $25.16 3.12M
Q3 2020 share Increase +44.93% 992K shares 14.24M $20.84 3.2M
Q2 2020 share Decrease -26.40% -792K shares -1.53M $23.75 2.20M
Q1 2020 share Increase +75.23% 1.28M shares 13.36M $17.99 3M
Q4 2019 share Increase 0.00% 1.71M shares 40.60M $23.72 1.71M